Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.

Source:http://linkedlifedata.com/resource/pubmed/id/11076653

Download in:

View as

General Info

PMID
11076653